EMEA-001857-PIP01-15

Key facts

Active substance
Elafibranor
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0237/2016
PIP number
EMEA-001857-PIP01-15
Pharmaceutical form(s)
  • Capsule, hard
  • Coated tablet
Condition(s) / indication(s)
Treatment of non-alcoholic fatty liver disease (NAFLD) including non-alcoholic steatohepatitis (NASH)
Route(s) of administration
Oral use
Contact for public enquiries
Genfit SA
France
Tel.+33 320164000
Fax +33 320164001
Email: contact@genfit.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating
Average
2 ratings